The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Berkeleyones and related meroterpenes from a deep water acid mine waste fungus that inhibit the production of interleukin 1-ß from induced inflammasomes.EBI
The University of Montana
Interleukin-1β converting enzyme (ICE): A comprehensive review on discovery and development of caspase-1 inhibitors.EBI
L J University Ahmedabad
Fragment-to-Lead Medicinal Chemistry Publications in 2022.EBI
Astex Pharmaceuticals
Ligandability Assessment of IL-1β by Integrated Hit Identification Approaches.EBI
Novartis
Human disorders associated with inflammation and the evolving role of natural products to overcome.EBI
University of Delhi
PROTEASE INHIBITORS AND METHODS OF USEBDB
The Cleveland Clinic Foundation
Aza-indazole compounds for use in tendon and/or ligament injuriesBDB
Novartis
Mutant IDH1 inhibitorsBDB
Eli Lilly
Substituted benzoxazoles and methods of use thereofBDB
Genentech
Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.BDB
Qingdao University
Inhibition of Src kinase activity by 4-anilino-7-thienyl-3-quinolinecarbonitriles.BDB
Wyeth Research